Neutral sphingomyelinase 2 (nSMase2) is a promising therapeutic target implicated in disease progression. We previously identified PDDC [phenyl (R)-(1-(3-(3,4-dimethoxyphenyl)-2,6-dimethylimidazo[1,2-b]pyridazin-8-yl)-pyrrolidin-3-yl) carbamate], a sub-micromolar nSMase2 inhibitor with favorable efficacy and pharmacokinetics in mice. However, poor aqueous solubility and suboptimal pharmacokinetics in higher species limited its translational potential.
Chae Bin
As seen in:
Color Research & Application,
Frontiers,
ACS Publications,
Pinkvilla,
IDN Times,
Kdramadiary
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Chae
Contact Chae, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack